Congestive hepatopathy secondary to graves’ disease: a case report

Authors

  • Steven Johanes Adrian Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia
  • I. Made Suma Wirawan Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.18203/2349-3933.ijam20222100

Keywords:

Congestive hepatopathy, Graves’ disease, Hyperthyroidism

Abstract

Graves’ disease is a common cause of hyperthyroidism in iodine-sufficient parts of the world. Excessive thyroid hormone is known to have multiple effects on various organs, including the liver. We reported a case of 49-year old male patient with worsening jaundice, ascites, tremor, and palpitation, with previous history of uncontrolled Graves’ disease. Findings from examination reveals signs of congestive hepatopathy, such as positive hepatojugular reflux and dilated hepatic vein. Treatment options for hyperthyroidism in patients with liver dysfunction includes methimazole and radioactive iodine-131. Liver dysfunction in patients with thyrotoxicosis is commonly found in daily practice, but establishing the cause of liver dysfunction can be a challenge because of the multiple cause of liver injury in hyperthyroidism.

Author Biographies

Steven Johanes Adrian, Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia

General Practitioner, Wangaya General Hospital, Denpasar, Bali, Indonesia

I. Made Suma Wirawan, Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia

Internist, Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia

References

Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301-16.

Diseases TIS of ETF on T. Indonesian Clinical Practice Guidelines for Hyperthyroidism. JAFES. 2014;27(1):34.

Mazo DF de C, de Vasconcelos GBS, Pereira MAA, de Mello ES, Bacchella T, Carrilho FJ et al. Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism. Clin Exp Gastroenterol. 2013;6(1):9.

Wafa B, Faten H, Mouna E, Fatma M, Mohamed A. Hyperthyroidism and hepatic dysfunction: Report of 17 cases. JGH Open. 2020;4(5):876-9.

Opoku-Akyeampong NAAS, Agyei-Nkansah A, Yorke E. Liver dysfunction associated with hyperthyroidism: Lessons from 2 Case reports. Clin Case Rep. 2021;9(6).

Yorke E. Hyperthyroidism and Liver Dysfunction: A Review of a Common Comorbidity. Clin Med Insights Endocrinol Diabetes. 2022;15.

Li C, Tan J, Zhang G, Meng Z, Wang R, Li W. Risk factors of hyperthyroidism with hepatic function injury: A 4-year retrospective study. Horm Metab Res. 2015;47(3):209-13.

Hilscher M, Sanchez W. Congestive hepatopathy. Clin Liver Dis. 2016;8(3):68.

Ziccardi MR, Pendela VS, Singhal M. Cardiac Cirrhosis. StatPearls. 2021.

Khemichian S, Fong T-L. Hepatic Dysfunction in Hyperthyroidism. Gastroenterol Hepatol (NY). 2011;7(5):337.

Vaidya Y, Bhatti H, Dhamoon AS. Hepatojugular Reflux. BMJ. 2021;318(7192):1172.

Wells ML, Fenstad ER, Poterucha JT, Hough DM, Young PM, Araoz PA et al. Imaging Findings of Congestive Hepatopathy. Radiographics. 2016;36(4):1024-37.

National Institute of Diabetes and Digestive and Kidney Diseases. Methimazole. 2020.

Lee SY. Clinical thyroidology ® 70 l Liver Enzymes Are Commonly Elevated in Untreated Hyperthyroidism and Improve after Correction of the Hyperthyroidism. Volume. 2021;33(2):2329-9711.

Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-421.

Wang R, Tan J, Zhang G, Zheng W, Li C. Risk factors of hepatic dysfunction in patients with Graves’ hyperthyroidism and the efficacy of 131iodine treatment. Medicine (Baltimore). 2017;96(5).

Downloads

Published

2022-08-24

Issue

Section

Case Reports